The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Theseus Pharmaceuticals(NASDAQ:THRX) 
Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-variant inhibitor for activating and resistance mutations of the KIT kinas...
Share this website to your friends
Theseus Pharmaceuticals Days Payable Outstanding ttm (DPO)
Theseus Pharmaceuticals Op Cashflow Per Share ttm
Theseus Pharmaceuticals Free Cashflow Per Share ttm
Theseus Pharmaceuticals Cash Per Share ttm
Theseus Pharmaceuticals (GAAP) P/E ratio ttm
Theseus Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.